Anagenics Ltd (AN1) - Total Liabilities
Based on the latest financial reports, Anagenics Ltd (AN1) has total liabilities worth AU$520.80K AUD (≈ $368.50K USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check AN1 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Anagenics Ltd - Total Liabilities Trend (2006–2026)
This chart illustrates how Anagenics Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Anagenics Ltd.
Anagenics Ltd Competitors by Total Liabilities
The table below lists competitors of Anagenics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Biophytis S.A.
NASDAQ:BPTSY
|
USA | $15.13 Million |
|
Capitan Investment Ltd
V:CAI
|
Canada | CA$1.24 Million |
|
Recrusul S/A
SA:RCSL3
|
Brazil | R$65.75 Million |
|
Henderson International Income Trust PLC
LSE:HINT
|
UK | GBX40.28 Million |
|
Inhalerx Ltd
AU:IRX
|
Australia | AU$2.38 Million |
|
ASIA Capital Group Public Company Limited
BK:ACAP
|
Thailand | ฿1.94 Billion |
|
Neola Medical AB
ST:NEOLA
|
Sweden | Skr6.86 Million |
|
Sultan Resources Ltd
AU:SLZ
|
Australia | AU$118.95K |
Liability Composition Analysis (2006–2026)
This chart breaks down Anagenics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See AN1 equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.27 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Anagenics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Anagenics Ltd (2006–2026)
The table below shows the annual total liabilities of Anagenics Ltd from 2006 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-06-30 | AU$520.80K ≈ $368.50K |
-77.11% |
| 2025-06-30 | AU$2.28 Million ≈ $1.61 Million |
-34.66% |
| 2024-06-30 | AU$3.48 Million ≈ $2.46 Million |
+57.09% |
| 2023-06-30 | AU$2.22 Million ≈ $1.57 Million |
-52.18% |
| 2022-06-30 | AU$4.64 Million ≈ $3.28 Million |
+62.14% |
| 2021-06-30 | AU$2.86 Million ≈ $2.02 Million |
-43.70% |
| 2020-06-30 | AU$5.08 Million ≈ $3.59 Million |
+29.04% |
| 2019-06-30 | AU$3.93 Million ≈ $2.78 Million |
-19.59% |
| 2018-06-30 | AU$4.89 Million ≈ $3.46 Million |
+20.01% |
| 2017-06-30 | AU$4.08 Million ≈ $2.88 Million |
+49.64% |
| 2016-06-30 | AU$2.72 Million ≈ $1.93 Million |
+14.79% |
| 2015-06-30 | AU$2.37 Million ≈ $1.68 Million |
+200.19% |
| 2014-06-30 | AU$790.70K ≈ $559.47K |
+14.83% |
| 2013-06-30 | AU$688.56K ≈ $487.20K |
+60.59% |
| 2012-06-30 | AU$428.78K ≈ $303.39K |
-45.30% |
| 2011-06-30 | AU$783.90K ≈ $554.66K |
+112.26% |
| 2010-06-30 | AU$369.31K ≈ $261.31K |
-23.66% |
| 2009-06-30 | AU$483.80K ≈ $342.32K |
-75.64% |
| 2008-06-30 | AU$1.99 Million ≈ $1.41 Million |
-37.60% |
| 2007-06-30 | AU$3.18 Million ≈ $2.25 Million |
+505.60% |
| 2006-06-30 | AU$525.45K ≈ $371.79K |
-- |
About Anagenics Ltd
Anagenics Limited engages in the health, wellness, and beauty business. The company develops, manufactures, and markets anti-ageing hair care products under the évolis brand name; and skin, hair, and body care products under the Uspa brand name. It also imports and distributes skin care and wellbeing products to spas, clinics, salons, retail stores, and online in Australia, New Zealand, and the P… Read more